The Fibroblast Growth Factor signaling pathway

Ornitz, David M., Itoh, Nobuyuki·2015·WIREs Developmental Biology

Cited by (1,019)

Items 101–200 of 1,019

  1. Neural Regeneration in Regenerative Endodontic Treatment: An Overview and Current Trends
    Yali Wei, Ping Lyu, R. Bi, Xinyu Chen, Yanshen Yu, Zu-Yi Li, Yi Fan · 2022 · International Journal of Molecular Sciences
  2. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities
    Shamaine Wei Ting Ho, Taotao Sheng, Manjie Xing, Wen Fong Ooi, Chang Xu, Raghav Sundar, Kie Kyon Huang, Zhimei Li, Vikrant Kumar, Kalpana Ramnarayanan et al. · 2022 · Gut
  3. Cancer cachexia: lessons from Drosophila
    Ying Liu, Pedro H. V. Saavedra, Norbert Perrimon · 2022 · Disease Models & Mechanisms
  4. Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling
    Jin-Fen Xiao, Andrew W. Caliri, Jason E. Duex, Dan Theodorescu · 2021 · Cancers
  5. Galectins as modulators of receptor tyrosine kinases signaling in health and disease
    Natalia Porębska, Marta Poźniak, Aleksandra Matynia, Dominika Żukowska, Małgorzata Zakrzewska, Jacek Otlewski, Łukasz Opaliński · 2021 · Cytokine & Growth Factor Reviews
  6. FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies
    Maxim Noeraparast, Katarina Krajina, Renate Pichler, D. Niedersüß-Beke, S. Shariat, Viktor Grünwald, S. Ahyai, Martin Pichler · 2024 · Cancer Communications
  7. Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis
    Yuichi Tsuchiya, Takao Seki, Kenta Kobayashi, Sachiko Komazawa‐Sakon, Shigeyuki Shichino, Takashi Nishina, Kyoko Fukuhara, Kenichi Ikejima, Hidenari Nagai, Yoshinori Igarashi et al. · 2023 · Nature Communications
  8. Chondrocyte Homeostasis and Differentiation: Transcriptional Control and Signaling in Healthy and Osteoarthritic Conditions
    Y. M. Michelacci, R. Baccarin, N. N. P. Rodrigues · 2023 · Life
  9. Medicinal chemistry perspective of pyrido[2,3- d ]pyrimidines as anticancer agents
    Adarsh Kumar, Kuber Kumar Bhagat, Ankit Kumar Singh, Harshwardhan Singh, Tanuja D. Angre, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid M. Emwas, Pradeep Kumar · 2023 · RSC Advances
  10. Roles of the fibroblast growth factor signal transduction system in tissue injury repair
    Keyang Chen, Zhiheng Rao, Siyang Dong, Yajing Chen, Xulan Wang, Yongde Luo, Fanghua Gong, Xiaokun Li · 2022 · Burns & Trauma
  11. Apoptotic stress-induced FGF signalling promotes non-cell autonomous resistance to cell death
    Florian J. Bock, Egor Sedov, Elle Koren, Anna L. Koessinger, Catherine Cloix, Désirée Zerbst, Dimitris Athineos, Jayanthi Anand, Kirsteen J. Campbell, Karen Blyth et al. · 2021 · Nature Communications
  12. Fgf9 regulates bone marrow mesenchymal stem cell fate and bone-fat balance in osteoporosis by PI3K/AKT/Hippo and MEK/ERK signaling
    Mingmei Chen, Hui Liang, Min Wu, Haoyang Ge, Yan Ma, Yan Shen, Shunyuan Lu, Chunling Shen, Hongxin Zhang, Zhugang Wang et al. · 2024 · International Journal of Biological Sciences
  13. FGF, Mechanism of Action, Role in Parkinson’s Disease, and Therapeutics
    Yiqiu Liu, Junyu Deng, Ye Liu, Wei Li, Xuqiang Nie · 2021 · Frontiers in Pharmacology
  14. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models
    Ranjithkumar Rajendran, Gregor Böttiger, Christine Stadelmann, Srikanth Karnati, Martin Berghoff · 2021 · Cells
  15. Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cells
    Mihir B Doshi, Namgyu Lee, T. Tseyang, Olga Ponomarova, H. Goel, Meghan E. Spears, Rui Li, L. Zhu, Christopher Ashwood, Karl Simin et al. · 2023 · Nature
  16. Phosphate-sensing and regulatory mechanism of FGF23 production
    Takashi, Y., Fukumoto, S. · 2020 · Journal of Endocrinological Investigation
  17. Metabolic Messengers: fibroblast growth factor 1
    Emanuel Gasser, Gencer Sancar, M. Downes, R. Evans · 2022 · Nature Metabolism
  18. The computational capabilities of many-to-many protein interaction networks
    Heidi E. Klumpe, J. García-Ojalvo, M. Elowitz, Y. Antebi · 2023 · Cell Systems
  19. ERK-mediated Curvature Feedback Regulates Branching Morphogenesis in Lung Epithelial Tissue
    Tsuyoshi Hirashima, M. Matsuda · 2021 · bioRxiv
  20. Time-integrated BMP signaling determines fate in a stem cell model for early human development
    Seth Teague, Gillian Primavera, Bohan Chen, Zong-Yuan Liu, LiAng Yao, Emily Freeburne, Hina Khan, Kyoung Jo, Craig N. Johnson, Idse Heemskerk · 2024 · Nature Communications
  21. Lung cancer organoids, a promising model still with long way to go
    Haochuan Ma, Yan-juan Zhu, Rui Zhou, Yaya Yu, Zhenzhen Xiao, Hai-bo Zhang · 2022 · Critical Reviews in Oncology/Hematology
  22. Novel targetable FGFR2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs
    M. Georgescu, M. Z. Islam, Yan Li, J. Traylor, A. Nanda · 2021 · Acta Neuropathologica Communications
  23. The role of microglial activation on ischemic stroke: Modulation by fibroblast growth factors
    Confidence Dordoe, Wenting Huang, Canol Bwalya, Xue Wang, Bi‐Xin Shen, Hao Wang, Jing Wang, Shasha Ye, Peng Wang, Bao Xiaoyan et al. · 2023 · Cytokine & Growth Factor Reviews
  24. RTK Inhibitors in Melanoma: From Bench to Bedside
    Malak Sabbah, Ahmad Najem, Mohammad Krayem, A. Awada, F. Journé, G. Ghanem · 2021 · Cancers
  25. Optimization of Vascularized Intestinal Organoid Model
    Zhang Wen, Mariabelen Orduno, Zixie Liang, Xiangyu Gong, Michael Mak · 2024 · Advanced Healthcare Materials
  26. B3GALT6 Promotes Dormant Breast Cancer Cell Survival and Recurrence by Enabling Heparan Sulfate-Mediated FGF Signaling
    Amulya Sreekumar, M. Lu, B. Choudhury, Tien-Chi Pan, D. Pant, Matthew R. Lawrence-Paul, Christopher J. Sterner, G. Belka, Takeshi Toriumi, B. Benz et al. · 2023 · bioRxiv
  27. Gene expression dynamics underlying cell fate emergence in 2D micropatterned human embryonic stem cell gastruloids
    Kyaw Thu Minn, S. Dietmann, S. Waye, Samantha A. Morris, L. Solnica-Krezel · 2021 · Stem Cell Reports
  28. Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia.
    R. Hudkins, Eric L Allen, Alexandra Balcer, I. Hoffman, Samhita Iyer, Melissa Neal, K. Nelson, M. Rideout, Qing Ye, Jacqueline H. Starrett et al. · 2024 · Journal of Medicinal Chemistry
  29. Structure-based drug-development study against fibroblast growth factor receptor 2: molecular docking and Molecular dynamics simulation approaches
    Anas Shamsi, Mohd Shahnawaz Khan, D. K. Yadav, M. Shahwan, Dr Mohammad Furkan, R. H. Khan · 2024 · Scientific Reports
  30. FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma
    Zhanchao Tao, Yue Cui, Xilong Xu, Ting Han · 2022 · Proceedings of the National Academy of Sciences
  31. Endothelial FGF signaling is protective in hypoxia-induced pulmonary hypertension.
    Kel Vin Woo, Isabel Y. Shen, C. Weinheimer, A. Kovács, Jessica Nigro, Chieh-Yu Lin, Murali M. Chakinala, D. Byers, D. Ornitz · 2021 · Journal of Clinical Investigation
  32. FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer.
    Jing Zhao, Wenxi Tan, Lingyi Zhang, Jian Liu, Mengyuan Shangguan, Junyu Chen, Ben-Zheng Zhao, Yuanqing Peng, Man-Hua Cui, Shuhua Zhao · 2021 · Biochemical Pharmacology
  33. FGF21 and Chronic Kidney Disease.
    J. Salgado, M. A. Goes, N. Salgado · 2021 · Metabolism: Clinical and Experimental
  34. Glucagon receptor signaling regulates weight loss via central KLB receptor complexes
    Nason, Shelly R., Antipenko, Jessica, Presedo, Natalie, Cunningham, Stephen E., Pierre, Tanya H., Kim, Teayoun, Paul, Jodi R., Holleman, Cassie, Young, Martin E., Gamble, Karen L. et al. · 2021 · JCI Insight
  35. Granulosa Cells: Central Regulators of Female Fertility
    L. F. Schütz, I. Batalha · 2024 · Endocrines
  36. Emerging roles of PLCγ1 in endothelial biology
    Dong-Ying Chen, M. Simons · 2021 · Science Signaling
  37. Mesenchymal stem cells for cartilage regeneration: Insights into molecular mechanism and therapeutic strategies.
    M. Mamachan, K. Sharun, S. A. Banu, S. Muthu, A. Pawde, L. Abualigah, S. K. Maiti · 2024 · Tissue & Cell
  38. Exploring the Role of the Gut and Intratumoral Microbiomes in Tumor Progression and Metastasis
    Aneta Ševčíková, Beáta Mladosievičová, Michal Mego, Soňa Čierniková · 2023 · International Journal of Molecular Sciences
  39. Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers
    Lauren M. Brown, Paul G. Ekert, Emmy D.G. Fleuren · 2023 · Oncogene
  40. Osteomalacia in Adults: A Practical Insight for Clinicians
    L. Arboleya, Ignacio Braña, E. Pardo, M. Loredo, R. Queiró · 2023 · Journal of Clinical Medicine
  41. The role of BMP4 in adipose-derived stem cell differentiation: A minireview
    Abdul Malik Setiawan, Taty Anna Kamarudin, Norzana Abd Ghafar · 2022 · Frontiers in Cell and Developmental Biology
  42. Regulation of aromatase in cancer
    Deborah Molehin, Fahmida Akter Rasha, Rakhshanda Layeequr Rahman, Kevin Pruitt · 2021 · Molecular and Cellular Biochemistry
  43. Relationships of serum FGF23 and α-klotho with atherosclerosis in patients with type 2 diabetes mellitus
    Jiao Bi, Mei Zheng, Ke Li, Siwei Sun, Zihang Zhang, Nana Yan, Xueping Li · 2024 · Cardiovascular Diabetology
  44. The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis
    Joe E. Mouawad, Carol A. Feghali‐Bostwick · 2023 · International Journal of Molecular Sciences
  45. Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments
    A. Gordon, Edwina Johnston, David K. Lau, N. Starling · 2022 · OncoTargets and Therapy
  46. From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor.
    Lewis D Turner, C. Trinh, Ryan A Hubball, Kyle M Orritt, Chi-Chuan Lin, J. Burns, M. Knowles, C. Fishwick · 2021 · Journal of Medicinal Chemistry
  47. Mechanisms of endocrine resistance in hormone receptor-positive breast cancer
    Yuan Gao, Yang Yu, Mingqing Zhang, Wenjun Yu, Lihua Kang · 2024 · Frontiers in Oncology
  48. Fibroblast growth factor signaling in axons: from development to disease
    Diogo Tomé, Marta S. Dias, Joana Correia, Ramiro D. Almeida · 2023 · Cell Communication and Signaling
  49. The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human Volunteers
    M. Rosenstock, Leo Tseng, Andrew A. Pierce, E. Offman, Chao-Yin Chen, R. Charlton, M. Margalit, Hank Mansbach · 2023 · Journal of Pharmacology and Experimental Therapeutics
  50. Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease
    Dimitrios D. Raptis, C. Mantzoros, S. Polyzos · 2023 · Therapeutics and Clinical Risk Management
  51. Jack of all trades, master of each: the diversity of fibroblast growth factor signalling in eye development
    Neoklis Makrides, Qian Wang, C. Tao, Samuel Schwartz, Xin Zhang · 2021 · Open Biology
  52. Roles of the FGF-FGFR Signaling System in Cancer Development and Inflammation
    A. Wiedlocha, E. Haugsten, M. Zakrzewska · 2021 · Cells
  53. Targeting FGFR in intrahepatic cholangiocarcinoma [iCCA]: leading the way for precision medicine in biliary tract cancer [BTC]?
    Gabriella Aitcheson, A. Mahipal, Binu V. John · 2021 · Expert Opinion on Investigational Drugs
  54. CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung Cancer
    Prahallad, Anirudh, Weiss, Andreas, Voshol, Hans, Kerr, Grainne, Sprouffske, Kathleen, Yuan, Tina, Ruddy, David, Meistertzheim, Morgane, Kazic-Legueux, Malika, Kottarathil, Tina et al. · 2023 · Cancer Research
  55. Photobiomodulation at 660 nm Stimulates In Vitro Diabetic Wound Healing via the Ras/MAPK Pathway
    Patricia Kasowanjete, H. Abrahamse, N. Houreld · 2023 · Cells
  56. FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia
    Jungkyu Choi, Wooshik Choi, Yunji Joo, H. Chung, Dokyun Kim, S. Oh, Sang-Heon Kim · 2021 · npj Regenerative Medicine
  57. Role of Klotho in Hyperglycemia: Its Levels and Effects on Fibroblast Growth Factor Receptors, Glycolysis, and Glomerular Filtration
    M. Typiak, Tomasz Kulesza, P. Rachubik, D. Rogacka, Irena Audzeyenka, S. Angielski, M. Saleem, A. Piwkowska · 2021 · International Journal of Molecular Sciences
  58. Fgf10/Fgfr2b Signaling Orchestrates the Symphony of Molecular, Cellular, and Physical Processes Required for Harmonious Airway Branching Morphogenesis
    Matthew R. Jones, Lei Chong, S. Bellusci · 2021 · Frontiers in Cell and Developmental Biology
  59. Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers
    K. Shan, Shivani Dalal, N. N. Thaw Dar, Omani McLish, M. Salzberg, Brian Pico · 2024 · International Journal of Molecular Sciences
  60. Small Extracellular Vesicle‐Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma
    S. W. Wong, S. K. Tey, X. Mao, Hiu-Ling Fung, Zhi-Jie Xiao, D. Wong, Lung-Yi Mak, Man-Fung Yuen, I. Ng, Jing-Ping Yun et al. · 2023 · Advancement of science
  61. Mechanisms of skeletal muscle-tendon development and regeneration/healing as potential therapeutic targets.
    Yuki Yoshimoto, Y. Oishi · 2023 · Pharmacology and Therapeutics
  62. Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenoviruses
    Thavasyappan Thambi, JinWoo Hong, Arum R. Yoon, Chae‐Ok Yun · 2022 · Cancer Gene Therapy
  63. Single-cell RNA analysis identifies pre-migratory neural crest cells expressing markers of differentiated derivatives
    Ezra S. Lencer, Rytis Prekeris, Kristin Artinger · 2021 · eLife
  64. Targeting fibroblast growth factor receptors to combat aggressive ependymoma
    D. Lötsch, D. Kirchhofer, B. Englinger, Li Jiang, K. Okonechnikov, D. Senfter, A. Laemmerer, L. Gabler, C. Pirker, A. Donson et al. · 2021 · Acta Neuropathologica
  65. Rho-Kinase 1/2 Inhibition Prevents Transforming Growth Factor-β-Induced Effects on Pulmonary Remodeling and Repair
    Xin-Hui Wu, V. Verschut, M. Woest, J. Ng-Blichfeldt, Á. Matías, G. Villetti, A. Accetta, F. Facchinetti, R. Gosens, L. Kistemaker · 2021 · Frontiers in Pharmacology
  66. Revolutionizing Wound Healing: Exploring Scarless Solutions through Drug Delivery Innovations.
    S. Alavi, Seyed Zeinab Alavi, Mehru Nisa, Maedeh Koohi, Aun Raza, Hasan Ebrahimi Shahmabadi · 2024 · Molecular Pharmaceutics
  67. Spatial profiling of cancer-associated fibroblasts of sporadic early onset colon cancer microenvironment
    Satoru Furuhashi, Matias Alberto Bustos, Shodai Mizuno, Suyeon Ryu, Yalda B. Naeini, Anton J. Bilchik, Dave S.�B. Hoon · 2023 · npj Precision Oncology
  68. A Review of Photobiomodulation on PI3K/AKT/mTOR in Wound Healing
    Patricia Kasowanjete, S. Kumar, N. Houreld · 2023 · Journal of Photochemistry and Photobiology
  69. The FGF/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditions
    G. Parthasarathy, M. Pattison, C. Midkiff · 2023 · Journal of Neuroinflammation
  70. Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer
    Ze-Chen Wang, K. S. Anderson · 2022 · Cancer Journal
  71. Spatially resolved phosphoproteomics reveals fibroblast growth factor receptor recycling-driven regulation of autophagy and survival
    Joanne Watson, Harriet R. Ferguson, Rosie M. Brady, Jennifer Ferguson, Paul Fullwood, Hanyi Mo, Katherine Bexley, David Knight, Gareth J. Howell, Jean‐Marc Schwartz et al. · 2022 · Nature Communications
  72. KLF17 promotes human naïve pluripotency but is not required for its establishment
    Rebecca A. Lea, Afshan McCarthy, Stefan Boeing, Todd L. Fallesen, Kay T. Elder, Phil Snell, Leila Christie, Sarah Adkins, Valerie Shaikly, Mohamed Taranissi et al. · 2021 · Development
  73. FGF10 and Lipofibroblasts in Lung Homeostasis and Disease: Insights Gained From the Adipocytes
    Yuqing Lv, Qhaweni Dhlamini, Cheng-Shui Chen, Xiao-Kun Li, S. Bellusci, Jin-San Zhang · 2021 · Frontiers in Cell and Developmental Biology
  74. Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets
    Haijun Wang, Jie Yang, Ke Zhang, Jia Liu, Yushan Li, Wei Su, Na Song · 2021 · Frontiers in Pharmacology
  75. The roles of FGFR3 and c-MYC in urothelial bladder cancer
    D. E. Bogale · 2024 · Discover Oncology
  76. Menin directs regionalized decidual transformation through epigenetically setting PTX3 to balance FGF and BMP signaling
    Meng-Ying Liu, Wenbo Deng, Lucy J. Tang, Meng-Ying Liu, H. Bao, Chuanhui Guo, Chang-Xian Zhang, Jinhua Lu, Haibin Wang, Zhongxian Lu et al. · 2022 · Nature Communications
  77. Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas
    A. Napolitano, A. Ostler, Robin L. Jones, Paul H. Huang · 2021 · Cells
  78. Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway
    Xiao-Wei Wu, Min-Jie Li, Ying Li, Yu Deng, S. Ke, Fan Li, Yu-Jin Wang, Shu-Chang Zhou · 2021 · Journal of Translational Medicine
  79. Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice
    S. Hadzic, Cheng-Yu Wu, M. Gredic, O. Pak, E. Loku, S. Kraut, B. Kojonazarov, Jochen Wilhelm, M. Brosien, M. Bednorz et al. · 2023 · European Respiratory Journal
  80. Fibroblast growth factor 10 ameliorates neurodegeneration in mouse and cellular models of Alzheimer's disease via reducing tau hyperphosphorylation and neuronal apoptosis
    Kaiming Guo, Wenting Huang, Kun-Huang-Yu Chen, Pengkai Huang, Wenshuo Peng, Rui-Qing Shi, Tao He, Mulan Zhang, Hao Wang, Jian Hu et al. · 2023 · Aging Cell
  81. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis
    Xin Li, Jianbo Zhou, Xue Bing Wang, Chunxi Li, Zifan Ma, Qiaoling Wan, Fu Peng · 2023 · Biomedicine & Pharmacotherapy
  82. Integrated regulation of chondrogenic differentiation in mesenchymal stem cells and differentiation of cancer cells
    Xiaohui Yang, S. Tian, Lin-Lin Fan, Rui Niu, Man Yan, Shuo Chen, Minying Zheng, Shi-Wu Zhang · 2022 · Cancer Cell International
  83. Repression of Osmr and Fgfr1 by miR-1/133a prevents cardiomyocyte dedifferentiation and cell cycle entry in the adult heart
    M. Valussi, J. Besser, Katharina Wystub-Lis, S. Zukunft, M. Richter, T. Kubin, T. Boettger, T. Braun · 2021 · Science Advances
  84. Receptor clustering by a precise set of extracellular galectins initiates FGFR signaling
    D. Żukowska, Aleksandra Gędaj, Natalia Porębska, Marta Poźniak, M. Krzyścik, Aleksandra A. Czyrek, D. Krowarsch, M. Zakrzewska, J. Otlewski, Lukasz Opalinski · 2023 · Cellular and Molecular Life Sciences
  85. Fibroblast growth factor-2 bound to specific dermal fibroblast-derived extracellular vesicles is protected from degradation
    I. Petit, Ayelet Levy, S. Estrach, C. Féral, A. Trentin, F. Dingli, D. Loew, J. Qu, H. Zhou, C. Théry et al. · 2022 · Scientific Reports
  86. Cranial Base Synchondrosis: Chondrocytes at the Hub
    Shawn A. Hallett, W. Ono, R. Franceschi, Noriaki Ono · 2022 · International Journal of Molecular Sciences
  87. AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer
    Abdulmelik Aytatlı, Neslişah Barlak, Fatma Şanli, H. Caglar, B. Gundogdu, A. Tatar, M. Ittmann, O. Karatas · 2021 · Cellular Oncology
  88. The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
    Junyu Deng, Ye Liu, Yi-Qiu Liu, Wei Li, Xu-Qiang Nie · 2021 · Journal of Inflammation Research
  89. Tyrosine kinases in the pathogenesis of tissue fibrosis in systemic sclerosis and potential therapeutic role of their inhibition
    Fabian A. Mendoza, Sonsoles Piera-Velázquez, Sergio A. Jiménez · 2021 · Translational research
  90. Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
    Mohd Mustafa, Kashif Abbas, Mudassir Alam, Safia Habib, Zulfareen, G. Hasan, Sidra Islam, Anas Shamsi, Imtaiyaz Hassan · 2024 · Frontiers in Oncology
  91. Protein-modified nanomaterials: emerging trends in skin wound healing
    Deepinder Sharda, Pawandeep Kaur, Diptiman Choudhury · 2023 · Discover Nano
  92. FGF12 is a novel component of the nucleolar NOLC1/TCOF1 ribosome biogenesis complex
    Martyna Sochacka, Radoslaw Karelus, Lukasz Opalinski, D. Krowarsch, Martyna Biaduń, J. Otlewski, M. Zakrzewska · 2022 · Cell Communication and Signaling
  93. The Effects of FGF4 Retrogenes on Canine Morphology
    D. Bannasch, Kevin Batcher, F. Leuthard, M. Bannasch, P. Hug, D. Marcellin-Little, P. Dickinson, M. Drögemüller, C. Drögemüller, T. Leeb · 2022 · Genes
  94. FGF signalling facilitates cervical cancer progression
    Hiba-Tun-Noor A. Mahmood, Elena Tomás-Bort, A. J. Walker, R. Grose, A. Chioni · 2021 · The FEBS Journal
  95. Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions
    M. Repetto, E. Crimini, F. Giugliano, S. Morganti, C. Belli, G. Curigliano · 2021 · Expert Review of Clinical Pharmacology
  96. Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation
    Heng-Huan Lee, Ying-Nai Wang, Wen-Hao Yang, W. Xia, Yong-Kun Wei, Li-Chuan Chan, Yu-Han Wang, Zhou Jiang, Shouping Xu, Jun Yao et al. · 2021 · Nature Communications
  97. Fibroblast growth factor 10 attenuates chronic obstructive pulmonary disease by protecting against glycocalyx impairment and endothelial apoptosis
    Tian-Rong Jiang, Weiping Hu, Shao-Yuan Zhang, Changhao Ren, Si-Yun Lin, Zhenyu Zhou, Hao Wu, Jun Yin, L. Tan · 2022 · Respiratory Research
  98. Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer
    H. A. Nicholson, Lynne Sawers, R. Clarke, K. Hiom, M. Ferguson, Gillian Smith · 2022 · British Journal of Cancer
  99. Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma.
    Z. Zengin, A. Chehrazi-Raffle, N. Salgia, R. Muddasani, Sana Ali, L. Meza, S. Pal · 2021 · Urologic oncology
  100. Association of FGF‐19 and FGF‐21 levels with primary sarcopenia
    Rabia Bağ Soytaş, Veysel Suzan, Pınar Arman, Tuğçe Emiroğlu Gedik, Damla Unal, M. Cengiz, I. Bolayırlı, Deniz Suna Erdinçler, A. Doventas, H. Yavuzer · 2021 · Geriatrics & Gerontology International